201 related articles for article (PubMed ID: 3109729)
21. Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth.
Chiabrando C; Broggini M; Castagnoli MN; Donelli MG; Noseda A; Visintainer M; Garattini S; Fanelli R
Cancer Res; 1985 Aug; 45(8):3605-8. PubMed ID: 3926304
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells.
Aliño SF; Unda FJ; Iruarrizaga A; Alfaro J; Hilario E; Pérez-Yarza G; Bobadilla M; Lejarreta M
Lab Invest; 1992 Jun; 66(6):671-9. PubMed ID: 1602737
[TBL] [Abstract][Full Text] [Related]
23. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of growth and metastasis of Lewis lung carcinoma in C57BL mice immunized with PGE2-bovine thyroglobulin conjugate].
Li W
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):427-9. PubMed ID: 1576908
[TBL] [Abstract][Full Text] [Related]
25. Autocrine regulation of corneal endothelium by prostaglandin E2.
Jumblatt MM
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2783-90. PubMed ID: 8188473
[TBL] [Abstract][Full Text] [Related]
26. Protein phosphatase-2A associates with the cytoskeleton to maintain cell spreading and reduced motility of nonmetastatic Lewis lung carcinoma cells: the loss of this regulatory control in metastatic cells.
Jackson J; Meisinger J; Patel S; Lim ZC; Vellody K; Metz R; Young MR
Invasion Metastasis; 1997; 17(4):199-209. PubMed ID: 9778592
[TBL] [Abstract][Full Text] [Related]
27. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.
Young MR; Newby M; Wepsic HT
Cancer Res; 1987 Jan; 47(1):100-5. PubMed ID: 2947676
[TBL] [Abstract][Full Text] [Related]
28. Linoleic acid metabolism in metastatic and nonmetastatic murine mammary tumor cells.
Chapkin RS; Hubbard NE; Buckman DK; Erickson KL
Cancer Res; 1989 Sep; 49(17):4724-8. PubMed ID: 2503244
[TBL] [Abstract][Full Text] [Related]
29. Role of the prostaglandin E2 receptor in mammary tumor metastasis.
Fulton AM; Zhang SZ; Chong YC
Cancer Res; 1991 Apr; 51(8):2047-50. PubMed ID: 1849040
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Maca RD
Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
[TBL] [Abstract][Full Text] [Related]
31. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
Nakanishi H; Oguri K; Takenaga K; Hosoda S; Okayama M
Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis.
Young MR; Halpin J; Hussain R; Lozano Y; Djordjevic A; Devata S; Matthews JP; Wright MA
Invasion Metastasis; 1993; 13(4):169-77. PubMed ID: 8034438
[TBL] [Abstract][Full Text] [Related]
33. Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis.
Yamashina K; Fulton A; Heppner G
J Natl Cancer Inst; 1985 Oct; 75(4):765-70. PubMed ID: 3862907
[TBL] [Abstract][Full Text] [Related]
34. Metastatic heterogeneity of cells from Lewis lung carcinoma.
van Lamsweerde AL; Henry N; Vaes G
Cancer Res; 1983 Nov; 43(11):5314-20. PubMed ID: 6616467
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
Milanovich MR; Snyderman CH; Wagner R; Johnson JT
Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
[TBL] [Abstract][Full Text] [Related]
36. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
Young MR; Aquino S; Young ME
J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
[TBL] [Abstract][Full Text] [Related]
37. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma.
Eisenbach L; Segal S; Feldman M
J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489
[TBL] [Abstract][Full Text] [Related]
38. Adhesiveness and morphology of Lewis lung carcinoma variants influence their sensitivity to natural killer cytolysis and their metastatic capacity.
Young MR; Duffie GP; Newby M
Invasion Metastasis; 1987; 7(2):96-108. PubMed ID: 3583624
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
40. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Mahalingam M; Ugen KE; Kao KJ; Klein PA
Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
